Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
277.00    -12.00 (-4.15%)
Bid:
275.00
Ask:
279.00
Spread: 4.00 (1.455%)
Market Cap: £248.99m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Interim Management Statement

12 Aug 2009 07:00

RNS Number : 2775X
Norcros PLC
12 August 2009
 



Norcros plc

("Norcros", the "Group" or the "Company")

Interim Management Statement

Norcros, the home consumer products group publishes its Interim Management Statement covering the 18 week period to 2 August 2009.

The Group announced its results for the year ended 31 March 2009 on 31 July 2009 and commented then that "we expect conditions will continue to be tough in the current year but having stabilised the performance of the business we are aiming to improve returns". There has been no material change to the trading environment since this date.

Group revenues for the period increased by 2.1% in Sterling but declined by 3.7% on a constant currency basis relative to the comparable period last year, reflecting a revenue decline of 1.5% in our UK operations and constant currency revenue declines of 6.6% and 7.7% in our South African and our Rest of the World operations respectively.

 

UK

 

Our UK businesses continue to perform well in testing market conditions. 

Triton, the UK market leader in domestic showers, experienced stabilisation in its UK performance growing UK revenues by 3.2%. Export revenues, representing c17% of Triton's total sales, continued to be impacted by the contraction in activity in the Irish market and declined by 22.9%. As a result, Triton's overall revenues declined by 2.5%. 

Johnson Tiles, a leading UK manufacturer and supplier of ceramic tiles, recorded particularly strong performance in the UK retail segment on the back of new product introductions and range changes. Overall UK revenues were ahead by 1.5% despite lower trade revenues. Export revenues, representing c13% of Johnson Tiles' total sales, were 12.5% lower. As a result, Johnson Tiles overall revenues were lower by 0.6% in the period.

The rate of new business growth in our UK adhesives business slowed with total revenues in line with the comparable period last year.

South Africa

 

In South Africa, our performance continues to be impacted by the lower levels of market demand with no appreciable change in activity levels experienced in the period. The new senior management team is settling in well and has identified further actions to improve efficiencies in both the tile manufacturing and retail operations.

Our retail operation, Tile Africa, experienced a constant currency revenue decline of 4.3% with new store gains partly offsetting LFL declines of 13.6%. TAL, our adhesive operation, recorded a decline in constant currency revenues of 12.0 % reflecting in particular a lower level of demand in its tile and building construction business segments limited by market share gains and new product introductions. Johnson Tiles, our tile manufacturing operation, also recorded revenues in constant currency lower by 9.5%. 

Overall revenues declined by 6.6% in constant currency but were higher by 9.4% in Sterling.

12 August 2009

  ENQUIRIES:

Norcros plc

Tel: 01625 547700

Joe Matthews, Group Chief Executive

Nick Kelsall, Group Finance Director

Altium

Tel: 0161 831 9133

Phil Adams

Mike Fletcher

College Hill

Tel: 020 7457 2020

Mark Garraway

Adam Aljewicz

For further information please visit the Company website:

www.norcros.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASPFFLXNEFE
Date   Source Headline
1st Jul 20217:00 amRNSVoting Rights and Share Capital Update
18th Jun 20217:00 amRNSAnnual Report & AGM announcement
17th Jun 20212:01 pmRNSHolding(s) in Company
10th Jun 20217:01 amRNSDirectorate Change
10th Jun 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSVoting Rights and Share Capital Update
30th Apr 20219:24 amRNSTotal Voting Rights
23rd Apr 202110:56 amRNSDirector Declaration
15th Apr 20217:01 amRNSDirectorate Change
15th Apr 20217:00 amRNSTrading Update
31st Mar 20212:49 pmRNSDirector Declaration
31st Mar 202112:11 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSTrading Update
9th Mar 20214:58 pmRNSDirector Shareholding
3rd Mar 20217:00 amRNSTrading Update
2nd Mar 20215:28 pmRNSTotal Voting Rights
2nd Mar 20214:38 pmRNSHolding(s) in Company
23rd Dec 202012:08 pmRNSEmployee SAYE awards and director shareholding
22nd Dec 20207:00 amRNSVoting Rights and Share Capital Update
8th Dec 20202:57 pmRNSHolding(s) in Company
30th Nov 20204:57 pmRNSVoting Rights and Share Capital Update
23rd Nov 20203:12 pmRNSDirectors' Dealings - APSP Share Option awards
17th Nov 20203:28 pmRNSHolding(s) in Company
16th Nov 20205:17 pmRNSDirectors' Dealings
12th Nov 20207:00 amRNSInterim Results
4th Nov 20205:35 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
30th Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
25th Aug 20204:36 pmRNSPrice Monitoring Extension
30th Jul 20202:06 pmRNSResults of AGM
30th Jul 20207:00 amRNSAGM Trading Statement
24th Jul 20209:33 amRNSHolding(s) in Company
15th Jul 20204:40 pmRNSSecond Price Monitoring Extn
15th Jul 20204:35 pmRNSPrice Monitoring Extension
6th Jul 202012:35 pmRNSHolding(s) in Company
3rd Jul 20207:00 amRNSAGM & Annual report announcement
25th Jun 20204:41 pmRNSSecond Price Monitoring Extn
25th Jun 20204:35 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSFinal Results
23rd Jun 202010:54 amRNSNotice of Results
22nd Jun 202010:44 amRNSHolding(s) in Company
1st May 20202:41 pmRNSVoting Rights and Share Capital Update
27th Apr 20205:49 pmRNSDirector Declaration
9th Apr 20209:35 amRNSHolding(s) in Company
8th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 202011:39 amRNSDirector's Shareholdings
3rd Apr 202011:21 amRNSDirector's Shareholding
1st Apr 20207:00 amRNSTrading update
30th Mar 202012:07 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.